Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
GS1 QR codes with digital links invite new opportunities for brands to engage with customers, transforming packaging into a ...